Filing Details
- Accession Number:
- 0001171843-15-001222
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-03 16:16:25
- Reporting Period:
- 2015-03-03
- Filing Date:
- 2015-03-03
- Accepted Time:
- 2015-03-03 16:16:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234734 | Rajat Rai | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-03 | 5,000 | $47.70 | 2,161,235 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $47.64 to $47.79 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at separate prices within the foregoing range.